Is Medtronic Stock Underperforming the Dow?

Medtronic plc (MDT) is a healthcare technology company with a market cap of $117.8 billion, providing solutions for cardiac devices, surgical robotics, insulin pumps, surgical tools, and patient monitoring systems, serving patients across more than 150 countries. Outperforming the Dow Jones Industrials Average by 27.1% over the past three months, MDT stock has fallen 12.1% from its 52-week high of $106.33 and trails the Dow by 10.7%.

Since mid-February, the stock has fallen below its 50-day and 200-day moving averages, but has since moved above its 50-day moving average in July. Analysts rate MDT as a "Moderate Buy," with a mean price target of $98.15, representing a 3.9% premium to its current level.